119 related articles for article (PubMed ID: 11687974)
1. A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31.
Hu Z; Gomes I; Horrigan SK; Kravarusic J; Mar B; Arbieva Z; Chyna B; Fulton N; Edassery S; Raza A; Westbrook CA
Oncogene; 2001 Oct; 20(47):6946-54. PubMed ID: 11687974
[TBL] [Abstract][Full Text] [Related]
2. cDNA cloning and genomic structure of three genes localized to human chromosome band 5q31 encoding potential nuclear proteins.
Lai F; Godley LA; Fernald AA; Orelli BJ; Pamintuan L; Zhao N; Le Beau MM
Genomics; 2000 Nov; 70(1):123-30. PubMed ID: 11087669
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of KLHL3, a human homologue of the Drosophila kelch gene.
Lai F; Orelli BJ; Till BG; Godley LA; Fernald AA; Pamintuan L; Le Beau MM
Genomics; 2000 May; 66(1):65-75. PubMed ID: 10843806
[TBL] [Abstract][Full Text] [Related]
5. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS
Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464
[TBL] [Abstract][Full Text] [Related]
6. Deletions of chromosome 5 in malignant myeloid disorders.
Le Beau MM
Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
[TBL] [Abstract][Full Text] [Related]
7. TTID: A novel gene at 5q31 encoding a protein with titin-like features.
Godley LA; Lai F; Liu J; Zhao N; Le Beau MM
Genomics; 1999 Sep; 60(2):226-33. PubMed ID: 10486214
[TBL] [Abstract][Full Text] [Related]
8. Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.
Sweetser DA; Peniket AJ; Haaland C; Blomberg AA; Zhang Y; Zaidi ST; Dayyani F; Zhao Z; Heerema NA; Boultwood J; Dewald GW; Paietta E; Slovak ML; Willman CL; Wainscoat JS; Bernstein ID; Daly SB
Genes Chromosomes Cancer; 2005 Nov; 44(3):279-91. PubMed ID: 16015647
[TBL] [Abstract][Full Text] [Related]
9. Human CDC23: cDNA cloning, mapping to 5q31, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias.
Zhao N; Lai F; Fernald AA; Eisenbart JD; Espinosa R; Wang PW; Le Beau MM
Genomics; 1998 Oct; 53(2):184-90. PubMed ID: 9790767
[TBL] [Abstract][Full Text] [Related]
10. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.
Yoneda-Kato N; Look AT; Kirstein MN; Valentine MB; Raimondi SC; Cohen KJ; Carroll AJ; Morris SW
Oncogene; 1996 Jan; 12(2):265-75. PubMed ID: 8570204
[TBL] [Abstract][Full Text] [Related]
11. Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
Lai F; Godley LA; Joslin J; Fernald AA; Liu J; Espinosa R; Zhao N; Pamintuan L; Till BG; Larson RA; Qian Z; Le Beau MM
Genomics; 2001 Jan; 71(2):235-45. PubMed ID: 11161817
[TBL] [Abstract][Full Text] [Related]
12. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
Pedersen B
Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
[TBL] [Abstract][Full Text] [Related]
13. Transcription mapping of the 5q- syndrome critical region: cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs.
Boultwood J; Fidler C; Strickson AJ; Watkins F; Kostrzewa M; Jaju RJ; Müller U; Wainscoat JS
Genomics; 2000 May; 66(1):26-34. PubMed ID: 10843801
[TBL] [Abstract][Full Text] [Related]
14. cDNA cloning, tissue distribution, and chromosomal localization of myelodysplasia/myeloid leukemia factor 2 (MLF2).
Kuefer MU; Look AT; Williams DC; Valentine V; Naeve CW; Behm FG; Mullersman JE; Yoneda-Kato N; Montgomery K; Kucherlapati R; Morris SW
Genomics; 1996 Jul; 35(2):392-6. PubMed ID: 8661158
[TBL] [Abstract][Full Text] [Related]
15. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
16. The novel human HUEL (C4orf1) gene maps to chromosome 4p12-p13 and encodes a nuclear protein containing the nuclear receptor interaction motif.
Sim DL; Chow VT
Genomics; 1999 Jul; 59(2):224-33. PubMed ID: 10409434
[TBL] [Abstract][Full Text] [Related]
17. Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval.
Horrigan SK; Westbrook CA; Kim AH; Banerjee M; Stock W; Larson RA
Blood; 1996 Oct; 88(7):2665-70. PubMed ID: 8839861
[TBL] [Abstract][Full Text] [Related]
18. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
Cabeza-Arvelaiz Y; Thompson TC; Sepulveda JL; Chinault AC
Oncogene; 2001 Oct; 20(46):6707-17. PubMed ID: 11709705
[TBL] [Abstract][Full Text] [Related]
19. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.
MacGrogan D; Kalakonda N; Alvarez S; Scandura JM; Boccuni P; Johansson B; Nimer SD
Genes Chromosomes Cancer; 2004 Nov; 41(3):203-13. PubMed ID: 15334543
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of JMJD2 family genes in silico.
Katoh M; Katoh M
Int J Oncol; 2004 Jun; 24(6):1623-8. PubMed ID: 15138608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
